Morinaga Milk Gains GRAS Status for Postbiotic Ingredient
Morinaga Milk's postbiotic LAC-Living+™ achieves self-affirmed GRAS status in the US, citing clinical evidence for mood and gut-brain well-being support.
Japanese dairy and functional ingredient company Morinaga Milk Industry Co., Ltd. has announced that its postbiotic ingredient LAC-Living+™ has achieved self-affirmed Generally Recognised as Safe (GRAS) status in the United States, according to a Business Wire announcement published 7 July 2026. The designation significantly expands commercial opportunities for the ingredient across North American food, beverage, and supplement markets, with the company citing clinical evidence supporting its role in mood and well-being.
Why This Matters for Gut-Brain Research
Postbiotics are a rapidly growing frontier in microbiome science, distinct from probiotics and prebiotics in that they comprise inactivated microbial cells or their by-products rather than live cultures. Interest in postbiotics has surged globally — including in the UK, where gut health research led by institutions such as King's College London and the University of Reading has helped establish the gut-brain connection as a legitimate and expanding field of study. GRAS status from a recognised regulatory body is a critical milestone for any functional ingredient seeking mainstream adoption, per the source announcement.
Clinical Evidence Links LAC-Living+™ to Mood and Well-Being
According to the Business Wire report, Morinaga Milk describes LAC-Living+™ as a clinically evidenced postbiotic designed to support mood and overall well-being. The company also highlights the ingredient's formulation flexibility, positioning it as suitable for diverse product applications across multiple categories. No specific clinical trial data, effect sizes, or population figures were disclosed in the available source material. The mood-and-gut-health angle aligns with a broader body of global research exploring how the gut microbiome communicates with the brain via the gut-brain axis.
What This Means for the Functional Food Industry
The GRAS milestone opens the door for Morinaga Milk to partner with US-based food, drink, and supplement manufacturers seeking clinically backed postbiotic ingredients — a category forecast to attract significant investment as consumer awareness of gut health grows worldwide. For UK industry observers and microbiome researchers, the development signals continued commercial momentum in postbiotic science, a space where British institutions and brands are also increasingly active. The gut-brain connection is fast becoming a key driver of product innovation across global health markets.
Morinaga Milk's GRAS achievement for LAC-Living+™ underscores the accelerating commercialisation of postbiotic ingredients backed by clinical research. As gut health and the gut-brain connection continue to capture consumer and scientific interest — in the UK and beyond — regulatory milestones such as this are likely to shape the next wave of functional food and supplement innovation.
You might also like
- Fasting-Mimicking Diet Cuts Gum Disease Inflammation
- How to Improve Gut Health Naturally in 5 Steps
- Gut Microbiome Research Unlocks New Cancer Care Hope
96 Bacterial Strains. Two Shots a Day.
GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?